Keywords: adams, resp, gets, not-approvable, letter, mucinex, codeine

Adams Resp gets "not-approvable letter" for Mucinex with Codeine

Article | 05 November 2007

The US Food and Drug Administration has issued an "approvable letter" on New Jersey-based Adams Respiratory Therapeutics' New Drug Application ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in